Accelerate Diagnostics, Inc Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Accelerate Diagnostics, Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Accelerate Diagnostics, Inc Return On Equity for the quarter ending June 30, 2024 was 131 %, a 55.1% decline year-over-year.
  • Accelerate Diagnostics, Inc annual Return On Equity for 2023 was 186 %, a 12% increase from 2022.
  • Accelerate Diagnostics, Inc annual Return On Equity for 2022 was 166 %, a 12.9% increase from 2021.
  • Accelerate Diagnostics, Inc annual Return On Equity for 2021 was 147 %, a 18.8% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 186 +19.9 +12% Jan 1, 2023 Dec 31, 2023
2022 166 +19 +12.9% Jan 1, 2022 Dec 31, 2022
2021 147 -34 -18.8% Jan 1, 2021 Dec 31, 2021
2020 181 +651 Jan 1, 2020 Dec 31, 2020
2019 -470 -364 -347% Jan 1, 2019 Dec 31, 2019
2018 -105 -49.4 -88.7% Jan 1, 2018 Dec 31, 2018
2017 -55.7 +11.7 +17.4% Jan 1, 2017 Dec 31, 2017
2016 -67.4 -2.76 -4.27% Jan 1, 2016 Dec 31, 2016
2015 -64.7 -16.3 -33.7% Jan 1, 2015 Dec 31, 2015
2014 -48.4 -5.96 -14.1% Jan 1, 2014 Dec 31, 2014
2013 -42.4 +33.4 +44.1% Jan 1, 2013 Dec 31, 2013
2012 -75.8 Aug 1, 2011 Jul 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.